Mitral Valve Prolapse and Infective Endocarditis

1993 ◽  
Vol 153 (12) ◽  
pp. 1506
Author(s):  
Alan L. Bisno
Keyword(s):  
Infective Endocarditis ◽  
Mitral Valve ◽  
Mitral Valve Prolapse

Mitral valve prolapse and infective endocarditis

1977 ◽  
Vol 63 (2) ◽  
pp. 215-222 ◽  
Author(s):  
Denton Corrigall ◽  
James Bolen ◽  
E.William Hancock ◽  
Richard L. Popp
Keyword(s):  
Infective Endocarditis ◽  
Mitral Valve ◽  
Mitral Valve Prolapse

MITRAL VALVE PROLAPSE AND INFECTIVE ENDOCARDITIS

The Lancet ◽  
1989 ◽  
Vol 334 (8672) ◽  
pp. 1165
Author(s):  
R. Prassler ◽  
Nicolas Danchin
Keyword(s):  
Infective Endocarditis ◽  
Mitral Valve ◽  
Mitral Valve Prolapse

Can Infectious Endocarditis during Pregnancy Be Cured with Only Drug Treatment?

2015 ◽  
Vol 18 (1) ◽  
pp. 033
Author(s):  
Serhat Caliskan ◽  
Feyzullah Besli ◽  
Saim Sag ◽  
Fatih Gungoren ◽  
Ibrahim Baran
Keyword(s):  
Infective Endocarditis ◽  
Mitral Valve ◽  
Mitral Regurgitation ◽  
Mitral Valve Prolapse ◽  
Treatment Options ◽  
Blood Cultures ◽  
Normal Vaginal Delivery ◽  
Posterior Leaflet ◽  
History Of ◽  
Current Guidelines

During pregnancy, infective endocarditis (IE) is quite rare but has a high mortality rate in terms of the mother and the fetus. In this article, a 24-year-old patient with a history of mitral valve prolapse (MVP) who was hospitalized due to IE and treated successfully is presented. On echocardiography, severe mitral valve prolapse, severe mitral regurgitation, and vegetation on the posterior leaflet of mitral valve were observed. Streptococcus mitis was subsequently isolated from four sets of blood cultures. The patient was diagnosed with IE. After 6 weeks of antibiotic therapy, the patient was cured completely without surgical treatment. At 40-weeks of pregnancy, the patient gave birth via a normal vaginal delivery. There were no problems with the 3,800-gram baby born. In current guidelines, there is very limited advice on treatment options for patients who develop IE during pregnancy. Therefore, evaluation of patient-based treatment options would be appropriate. In addition, IE prophylaxis for MVP is not recommended in current guidelines. However, in MVP patients with mitral regurgitation, prior to procedures associated with a high risk of infective endocarditis, IE prophylaxis may be rational.

Mitral valve prolapse and infective endocarditis

1987 ◽  
Vol 113 (5) ◽  
pp. 1291-1298 ◽  
Author(s):  
Stephen W MacMahon ◽  
J Kirk Roberts ◽  
Randi Kramer-Fox ◽  
David M Zucker ◽  
Richard B Roberts ◽  
...  
Keyword(s):  
Infective Endocarditis ◽  
Mitral Valve ◽  
Mitral Valve Prolapse

scholarly journals Association of Mitral Valve Prolapse With Infective Endocarditis Due to Viridans Group Streptococci: Table 1.

2015 ◽  
Vol 61 (4) ◽  
pp. 623-625 ◽  
Author(s):  
Daniel C. DeSimone ◽  
Christopher V. DeSimone ◽  
Imad M. Tleyjeh ◽  
Daniel D. Correa de Sa ◽  
Nandan S. Anavekar ◽  
...  
Keyword(s):  
Infective Endocarditis ◽  
Mitral Valve ◽  
Mitral Valve Prolapse ◽  
Viridans Group Streptococci

Clinical and health care cost consequences of infective endocarditis in mitral valve prolapse

1994 ◽  
Vol 73 (4) ◽  
pp. 263-267 ◽  
Author(s):  
Cynthia J. Frary ◽  
Richard B. Devereux ◽  
Randi Kramer-Fox ◽  
Richard B. Roberts ◽  
Hirsch S. Ruchlin
Keyword(s):  
Health Care ◽  
Infective Endocarditis ◽  
Mitral Valve ◽  
Mitral Valve Prolapse ◽  
Health Care Cost

Surgical treatment of mitral valve prolapse complicated by infective endocarditis

2009 ◽  
Vol 29 (2) ◽  
pp. 133-136
Author(s):  
Xin-wei YANG ◽  
Zhi-nong WANG ◽  
Zhi-yun XU ◽  
Bao-ren ZHANG ◽  
Liang-jian ZOU ◽  
...  
Keyword(s):  
Surgical Treatment ◽  
Infective Endocarditis ◽  
Mitral Valve ◽  
Mitral Valve Prolapse
Sign in / Sign up

Export Citation Format

Share Document